12-31
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- undated
- Valid until
- still holds
- Published
- no source on record carries a date
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
Sources
Cite this claim
Plain text
AsOf. "AstraZeneca fiscal year end: 12-31", undated. Claim clm_433F982364C7, https://asof.is/claim/clm_433F982364C7, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832.
APA
AsOf. (n.d.). AstraZeneca fiscal year end: 12-31 (undated) [Record clm_433F982364C7]. Retrieved November 9, 2026, from https://asof.is/claim/clm_433F982364C7 (source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832)
BibTeX
@misc{asof_clm_433F982364C7,
author = {AsOf},
title = {AstraZeneca fiscal year end: 12-31},
howpublished = {\url{https://asof.is/claim/clm_433F982364C7}},
note = {Claim clm\_433F982364C7, undated; source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany\&CIK=0000901832},
urldate = {2026-11-09}
}On the record
/claim/clm_433F982364C7.md/v1/claims/clm_433F982364C7submit a correction